We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





World's First Inhalable COVID-19 Vaccine Approved in China

By HospiMedica International staff writers
Posted on 06 Sep 2022
Print article
Image: The Convidecia Air inhalable COVID-19 vaccine has been approved for use as a booster dose (Photo courtesy of Pexels)
Image: The Convidecia Air inhalable COVID-19 vaccine has been approved for use as a booster dose (Photo courtesy of Pexels)

CanSino Biologics Inc. (Tianjin, China) has received approval from the National Medical Products Administration of China (NMPA) for Convidecia Air, its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation to be used as a booster dose.

Utilizing the same adenovirus vector technological platform as the company's intramuscular version Convidecia, Convidecia Air provides a non-invasive option that uses a nebulizer to change liquid into an aerosol for inhalation through the mouth. Convidecia Air is needle-free and can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath. Studies have indicated that Convidecia Air can induce strong humoral, cellular and mucosal immunity to achieve triple protection and effectively contain the infection and spread of the virus.

Related Links:
CanSino Biologics Inc. 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Pulmonary Artery Catheter
Swan-Ganz
New
LED Phototherapy System
neoBLUE compact

Print article

Channels

Surgical Techniques

view channel
Image: The zwitterionic coating could stop blood clots from forming in medical devices and implants (Photo courtesy of University of Sydney)

New Surface Coating Could Prevent Blood Clotting in Medical Devices and Implants

For people living with heart valve disease, medical devices such as heart valves and stents are critical in saving lives. These implants face constant pressure within the human body, with heart valves... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.